
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: The Medicare GLP-1 Bridge—What Independent Pharmacists Need to Know
2
Grocery Pharmacy Conglomerate to Pay $40 Million for Violating False Claims Act
3
HHS Claims ACIP Cannot Meet for Flu Season Due to Ongoing Legal Battle
4
US Controlled Substance Market Expected to Grow $21 Billion by 2035
5




































